MedTrace Logo

Post-market Study to Capture Information Regarding Performance of Lyric2

NCT01861704 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 177

Last updated 2014-05-19

Study results available
· View outcomes & findings →

Summary

Randomized post market study comparing Lyric to Lyric2 capturing information regarding comparative performance and safety.

Conditions

Interventions

DEVICE

Lyric

Extended wear hearing instrument

DEVICE

Lyric2

Extended wear hearing instrument

Sponsors & Collaborators

  • Phonak AG, Switzerland

    lead INDUSTRY

Principal Investigators

  • Tanya Arbogast · Employee

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-01-31
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01861704 on ClinicalTrials.gov